Another participant in de novo lipogenesis is glucokinase regulatory protein (GCKR), and the substitution of proline to leucine P446L in its encoding gene is associated with NAFLD progression [7,83,84]. Here, GCKR is linked to metabolic dysfunction-associated steatotic liver disease.